RenovoRx RNXT
NASDAQ RNXT
$1.30 -0.02 (-1.52%)
As of: Aug 21, 2026 · 1:11 PM EDT

RenovoRx (RNXT) EBIT Margin Growth (1y) (2026)

RenovoRx (RNXT) EBIT Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.29 Bn 131.44 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.31 Bn 78.32 Bn 3.93 Bn 78.00
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn 1,135.00
4 Moderna 58.92 Bn 53.78 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.07 Bn 36.97 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.70 Bn 28.39 Bn 992.69 Mn 2,002.00
7 BioNTech SE 27.99 Bn 9.60 Bn 668.28 Mn -3,558.00
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.28 Bn 26.45 Bn - -1,651.00
10 RenovoRx 61.49 Mn 61.49 Mn 766,000.00 26,617.00

Historic Data

Download Data
DateValue
Jun 30, 2026 26,617.00
Mar 31, 2026 96,252.00